Since being selected as CEO of Baxter International, the global medical-products company, in 1999, Harry Kraemer has transformed the company into one of the industry’s most successful and consistent growth engines. Revenue and operating profit have outpaced major indices over the past five years, with stockholder return surpassing both the S&P 500 and S&P Healthcare Composite. Although, 2002 brought unprecedented levels of economic, political, and competitive volatility, Baxter still delivered 10 percent sales growth for the year. In contrast, the median growth in revenues for Fortune 500 companies was just 1.2 percent in 2002.
Throughout his tenure at Baxter, Kraemer ...
No credit card required